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Abstract
Background: The convergent distribution of the Human Immunodeficiency Virus (HIV) and helminth infections has
led to the suggestion that infection with helminths exacerbates the HIV epidemic in developing countries. In South
Africa, it is estimated that 57% of the population lives in poverty and carries the highest burden of both HIV and
helmith infections, however, the disease interactions are under-researched.
Methods: We employed both coproscopy and Ascaris lumbricoides-specific serum IgE to increase diagnostic sensitivity
and to distinguish between different helminth infection phenotypes and their effects on immune responses in HIV co-
infected individuals. Coproscopy was done by formol ether and Kato Katz methods. HIV positive and negative adults
were stratified according to the presence or absence of A. lumbricoides and/or Trichuris trichuria eggs with or without
elevated Ascaris IgE. Lymphocyte subsets were phenotyped by flow cytometry. Viral loads, serum total IgE and
eosinophils were also analysed. Lymphocyte activation markers (CCR5, HLA-DR, CD25, CD38 and CD71) were
determined. Non parametric statistics were used to describe differences in the variables between the subgroups.
Results: Helminth prevalence ranged between 40%-60%. Four distinct subgroups of were identified, and this included
egg positive/high Ascaris-specific IgE (egg+IgEhi), egg positive/low IgE (egg+IgElo), egg negative/high IgE (egg-IgEhi) and
egg negative/low IgE (egg-IgElo) individuals. The egg+IgEhi subgroup displayed lymphocytopenia, eosinophilia, (low CD4+
counts in HIV- group), high viral load (in HIV+ group), and an activated lymphocyte profile. High Ascaris IgE subgroups
(egg+IgEhi and egg-IgEhi) had eosinophilia, highest viral loads, and lower CD4+ counts in the HIV- group). Egg excretion
and low IgE (egg+IgElo) status demonstrated a modified Th2 immune profile with a relatively competent response to HIV.
Conclusions: People with both helminth egg excretion and high Ascaris-IgE levels had dysregulated immune cells,
high viral loads with more immune activation. A modified Th2 helminth response in individuals with egg positive
stools and low Ascaris IgE showed a better HIV related immune profile. Future research on helminth-HIV co-
infection should include parasite-specific IgE measurements in addition to coproscopy to delineate the different
response phenotypes. Helminth infection affects the immune response to HIV in some individuals with high IgE
and egg excretion in stool.
Background
The convergent distribution of the Human Immunodefi-
ciency Virus (HIV) and helminth infections has been
widely associated with the notion that persistent infection
with helminths exacerbates the HIV epidemic in develop-
ing countries [1]. Chronic immune activation, altered
immune cell distribution, immune suppression, altered
cytokine profiles and strong T-helper 2 (Th2) bias
induced by helminths, are suggested to increase suscept-
ibility to the virus, enhancing its replication, increasing
HIV disease severity and facilitating faster progression to
AIDS [1,2]. The cellular and molecular immunological
mechanisms of interaction reviewed in these papers [1,2],
as well as many other epidemiological and immunologi-
cal reports elsewhere and in Africa, provide sound sug-
gestive evidence in support of the hypothesis [3-9].
* Correspondence: kwitshana@ukzn.ac.za
1Offfice of the Deputy Dean: Postgraduate and Research, NRM School of
Medicine, University of KwaZulu-Natal, P.O. Box 7, Congella, 4001, South
Africa
Full list of author information is available at the end of the article
Mkhize-Kwitshana et al. BMC Infectious Diseases 2011, 11:273
http://www.biomedcentral.com/1471-2334/11/273
© 2011 Mkhize-Kwitshana et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
South Africa (SA) has the highest number of HIV type 1
(HIV-1) infected individuals globally, about 5.6 million
people out of a population of 48 million were living with
HIV in 2010 [10]. Although the national estimates of hel-
minth prevalence are not known, data from surveys in dif-
ferent SA provinces reveal infestation levels that range
between 70-100% in school age children and preschoolers
[11-17]. An estimated 57% of the SA population lives in
poverty and carries most of the disease burden of the two
infections [18,19]. However, studies that analyse the
immunological interaction between these two disease con-
ditions are limited in the country.
A major challenge in studies of co-infection with
intestinal parasites is accurate laboratory diagnosis of the
helminth infection, particularly in adults. In such studies,
proper classification of helminth infection status is criti-
cal to avoid misinterpretation of results. It has been pro-
posed that sole reliance on the presence of parasite eggs
in stool to diagnose helminthiasis can lead to serious
misinterpretation of results [20]. Maizels and Yazdan-
bakhsh [21] presented three phenotypic outcomes of
helminth infection that are determined by antibody iso-
type (IgG4 and IgE) and T helper cell profiles. Each phe-
notype is characterised by specific immune responses to
helminths. In the present study, stool egg detection has
therefore been supplemented with serum Ascaris lumbri-
coides -specific IgE measurement. Four distinct sub-
groups, based on the presence or absence of stool eggs
with or without elevated serum Ascaris-specific IgE were
delineated. This paper reports the lymphocyte profiles
including eosinophil counts, viral loads and the activation
status in the defined subgroups.
Methods
Study design, setting and participants
Individuals in this study were a subgroup of adults (older
than 18 years) from a larger prospective deworming study
published in part elsewhere [20]. Ethical approval was
obtained from the South African Medical Research Coun-
cil and the University of Stellenbosch Ethics Committees.
Permission to conduct the study was granted by the Mat-
thew Goniwe Clinic management team. Written informed
consent, which included permission to do HIV testing,
was obtained from all participants.
The study was undertaken in Khayelitsha, Western Cape
Province (SA), an informal settlement with limited
resources, high helminth endemicity and HIV prevalence.
A survey of 12 primary schools in this settlement showed
that more than 90% of school children were infected by
helminths [22], while a recall study on the history of hel-
minth infection among adults showed that more than 70%
had been infested by helminths previously [20]. Within the
Western Cape Province, the prevalence of HIV in Khaye-
litsha (22%) was higher than the 9.1% provincial level [23].
Study participants were recruited from Mathew Goniwe
clinic between May 2002 and November 2003 for the
main study [20] and the present analyses commenced in
August 2004 to November 2005. The HIV positive indivi-
duals were purposively recruited from the HIV Positive
Support Group at the clinic, while the HIV negative were
adults accompanying patients to the clinic. The selection
criteria for the present study are outlined in Figure 1. All
participants were antiretroviral therapy naive as such treat-
ment was not routinely available to communities in SA at
the time. To exclude recent and present infectious diseases
and possible recent treatment for worms, the participants
and case record files were examined by the study clinician
and one-to-one interviews undertaken. Two stool samples,
collected on two consecutive days, and approximately
30 ml of blood were obtained from each participant.
Females provided fresh urine samples for b-HCG preg-
nancy screening.
Laboratory analyses
Detection of stool helminth eggs
Stool microscopy was performed by two independent
microscopists using the formol-ether concentration [24]
and the Kato Katz [25] methods respectively. Treatment
with Mebendazole (and Praziquantel where indicated) was
given to all participants with faecal helminth eggs. For this
study, only participants infested with A. lumbricoides and/
or T. trichiura were included.
HIV testing and viral loads
Confirmation of HIV status was done by a rapid test for
HIV (InstantScreen® Rapid HIV-1/2 Assay GAIFAR
GmbH, Germany) at the clinic. Serum was re-tested at
Tygerberg Academic Hospital, Department of Virology
using the Abbott Axsym® Microparticle Enzyme Immu-
noassay (MEIA) for the detection of antibodies to HIV-1
(subtypes M and O) and/or HIV-2. Confirmation of MEIA
positive tests was done by PCR sequencing of viral DNA.
HIV-1 viral load was determined by the Abbot LCx® HIV
RNA Quantitative assay (Abbott Q1Laboratories, IL) in
the same Virology department.
Full blood counts and serum IgE tests
Serum total and A. lumbricoides-specific IgE levels were
determined by CAP total IgE and ImmunoCAP® Specific
IgE (RAST), respectively. The cut-off for a positive Ascaris
IgE test was > 0.35 ku/L, the assay detection limit. Full
and differential blood counts were performed using the
H2 Technicon Analyser at the Tygerberg Hospital Haema-
tology laboratory on Ethylenediaminetetraacetic acid
(EDTA) -anticoagulated whole blood. The full blood
count results were used for the calculation of absolute
lymphocyte subset numbers in the dual-platform analysis.
Four- Colour immunophenotyping of T cell subsets
Lymphocyte subsets were phenotyped by the MultiT-
est, four colour, direct immunofluorescence on the
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flourescence-activated cell sorter (FACS) Calibur™,
Becton & Dickenson (BD) Biosciences, (San Jose, CA,
USA). EDTA anticoagulated whole blood of 149 HIV-1
positive participants and 45 HIV-1 negative controls
was stained with monoclonal antibodies (mAbs) to
lymphocyte surface markers labelled with flouro-
chromes as follows: Panel 1: CD45 Peridinin chloro-
phyll protein (PerCP); CD3 Flourescein Isothiocyanate
(FITC); CD4 Allophycocyanin (APC); CD8 Phyco-ery-
thrin (PE); Panel 2 CD3FITC;CD45 PerCP; CD19 APC;
CD16+CD56 PE. All mAbs were obtained from Becton
Dickinson (BD). Cells were stained within twenty four
hours of blood collection using the standard procedure
described in the BD MultiTest Reagent Package insert.
Stained samples were analysed on the FACS Calibur™
(BD) Neon-Argon dual laser flow cytometer. For each
sample, at least 10 000 events were acquired per tube
using the MultiSET™ (BD) software. The percentages
of each T and non-T lymphocyte subsets were deter-
mined. A double-platform method was then used to
calculate the absolute counts of each lymphocyte sub-
set from the total lymphocyte counts (from Haematol-
ogy counts) and the lymphocyte percentages obtained
by flow cytometry.
Peripheral blood mononuclear cell (PBMCs) preparation
PBMCs were separated by standard Ficoll Hypaque gradi-
ent centrifugation, suspended in fetal calf serum and 10%
v/v Dimethylsulfoxide and cryopreserved in Liquid Nitro-
gen. Later, cells were thawed and counts were done by a
phase-contrast microscope to simultaneously discrimi-
nate between viable and non-viable cells. Only samples
with more than 90% viable cells were used.
Four-colour flow cytometric analysis of activation markers
on PBMCs
Since the two chronic infections (HIV and helminths)
result in sustained immune activation, hypothetically,
Figure 1 Selection strategy for inclusion of participants for immunological analyses. **Among the HIV- eligible participants, 23 did not
submit the complete set of samples thus the remaining 22 were included by default.
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upregulation of activation markers on peripheral lym-
phocytes would be more pronounced in co-infected
individuals. To test this, the expression of CCR5, CD25,
HLA-DR, CD38 and CD71 were determined on CD3+,
CD4+ and CD8+ lymphocytes among HIV subgroups.
These subgroups were randomly selected from all 124
HIV+ eligible participants (every second participant,
using laboratory identifier numbers until there were 10
participants per subgroup). All the 22 HIV negative, eli-
gible participants with or without helminth infections
were included by default, for comparisons by HIV
status.
PBMCs from 40 HIV-1 positive participants and 22 HIV
negative controls were labelled with directly conjugated
monoclonal antibodies to various surface activation
markers to determine the ex-vivo activation status. The
procedure described in the BD Biosciences/Pharmingen
Catalogue [26] was modified for microtiter plates. Each
sample was stained in five different wells containing com-
binations of mAbs to surface markers directly conjugated
to fluorochromes as follows: CD3- PerCP; CD4-APC;
CD8-, HLA-DR- and CD71 -FITC; CD8-, CD38-, CD25-
and CCR5-PE. The following isotype controls (BD) were
included: IgG1k and IgG2a- FITC; IgG1k and IgG2a -PE;
IgG1k -PerCP and IgG2a -APC. All mAbs conjugates were
purchased from BD. Stained cells were analysed on the
FACS Calibur™ flow cytometer using BD FACS™ tubes.
A minimum of 10 000 events were acquired for each sam-
ple tube in list mode using the Cellquest software (BD).
Lymphocytes were gated on established regions and per-
centages of CD3, CD4 and CD8 cells expressing CCR5,
CD25, HLA-DR and CD71 were quantified.
Statistical analysis
Statistical analysis was conducted in STATA version 10.0
(Stata Corporation, College Station, Texas, USA). The nor-
mal distribution of recorded data was tested by the Sha-
piro Wilks tests and variables with skewed data were log-
transformed. As some of the variables remained skewed
after this transformation non-parametric tests were used.
The median was used as a measure of central tendency for
descriptive statistics. Kruskal Wallis was used to test for
differences in the medians and for multiple comparisons
of all measured variables between the subgroups in HIV
positive and HIV negative groups. A. p-value ≤ 0.05 was
considered to be statistically significant.
Results
Of the 151 eligible, seropositive participants who sub-
mitted blood and stool samples, lymphocyte phenotypes
were done on 149 individuals. Complete data for stratifica-
tion of helminth infection was obtained for 124 indivi-
duals. Forty-five HIV negative participants submitted the
samples and 39 were suitable for immunophenotypes and
22 could be stratified for helminthiasis. The demographic,
viral and immunologic profile of the two HIV groups is
summarized in Table 1. The reference ranges for the hea-
matological indices listed in this table had been established
for the local population by the Tygerberg Hospital’s Hae-
matology Department. The local lower limits for CD4+
and CD8+ cells differ from those of the international refer-
ence ranges [27-29].
Serum total IgE levels were 6-fold above the method
reference range among the HIV-1 sero-positive people
and 9-fold higher in the HIV-1 uninfected group while
Ascaris-specific IgE was 6 times and 8 times higher in the
two groups, respectively. The proportions by combined
measures of high serum Ascaris-specific IgE plus stool egg
positivity as indicators for helminth infection (>65%)
exceeded the percentage of participants with stool egg
positivity only (>40%) in both HIV positive and negative
groups (Table 1). A range of parasites was detected in this
adult population, including infection with more than one
species. The most prevalent infections were A. lumbri-
coides (44 of the 51 HIV+ egg positive and 14 of 18 HIV-
egg positive participants), followed by T. trichiura (30 of
51 HIV+ and 8 of 18 HIV- participants). Other parasites
included the Taenia species (5 of 51 and 3 of 18 HIV+ and
HIV- individuals respectively), Fasciola (one in each of the
two HIV-1 groups) and Schistosoma mansoni (one of the
18 HIV-1 negatives). Among the HIV-1+, 21 of 51 (41%)
were dually infected by A. lumbricoides and T. trichiura
and 5 out of 18 (28%) among HIV- group harboured both
these parasites. Worm burdens were lower in the HIV
positive group.
Stratification of helminth infection subgroups by
coproscopy and A. lumbricoides specific IgE (Ascaris IgE)
serology
Some participants excreted parasite eggs with or without
elevated A. lumbricoides IgE while others had high serum
A. lumbricoides IgE but did not excrete eggs. Four distinct
subgroups were stratified, among the HIV positive indivi-
duals. Subgroup 1 (n = 21) comprised of Trichuris and/or
Ascaris egg positive stool and elevated Ascaris IgE (egg
+IgEhi), a typical infection, subgroup 2 (n = 35) consisted
of Trichuris and/or Ascaris egg positive stool without ele-
vated Ascaris IgE (egg+IgElo), subgroup 3 (n = 21) con-
tained Trichuris and Ascaris egg negative stool but
elevated Ascaris IgE (egg-IgEhi), and subgroup 4 (n = 47)
included Trichuris and Ascaris egg negative stool and low
Ascaris IgE (egg-IgElo). Among the HIV negative partici-
pants the subgroups were egg+IgEhi (n = 9) egg+IgElo (n =
9), egg-IgEhi (n = 11) and egg-IgElo (n = 10).
Lymphocyte subsets, eosinophils and viral load in
subgroups
Total lymphocyte numbers and their subpopulations (T,
B, NK, CD4+ and CD8+), eosinophil counts and viral
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load were assessed in the four subgroups in HIV
infected and uninfected participants (Tables 2 and 3).
HIV singly-infected (egg-lgElo) versus the HIV and typical
helminth co-infected (egg+IgEhi) subgroup
The HIV-1+, egg-IgElo subgroup had the lowest CD4+
cells, T-lymphocyte counts and CD4:CD8 ratio than all
the subgroups. In addition, there was no statistically signif-
icant difference between HIV+egg+IgEhi and the HIV+egg-
IgElo subgroups in all measured variables except for eosi-
nophils which were significantly higher in the dually
infected individuals (Table 2).
HIV negative helminth uninfected (egg-IgElo) versus
typical helminth infected (egg+IgEhi) subgroup
Higher but not statistically significant absolute counts for
all T and non-T lymphocyte subsets were observed when
the egg-gElo was compared to the typical helminth infected
subgroup (egg+IgEhi). The egg-gElo subgroup had both
marginally non significant higher total lymphocyte counts
(p = 0.06) and lower eosinophils (p = 0.08). However, the
CD4:CD8 ratio was higher in the egg+IgEhi subgroup.
Typical helminth (egg+IgEhi) and HIV co-infected
subgroup
The HIV positive, egg+IgEhi subgroup had lymphocytope-
nia and statistically significant eosinophilia. Amongst the
subgroups with evidence of dual infection, in the HIV
positive egg+IgEhi group, the absolute values were lower
for all lymphocyte populations, compared to the overall
absolute counts for the entire HIV positive group (Table
1). The absolute values for all lymphocyte populations
in the HIV positive egg+IgEhi subgroup were also lower
compared to the egg+IgElo and the egg-IgEhi subgroups
(Table 2).
B lymphocytes were significantly lower in the egg+IgEhi
subgroup (p = 0.03) and CD4+ counts were marginally
non-significantly lower (p = 0.06) compared to the egg+-
IgElo subgroup.
The egg+IgEhi status was associated with more fre-
quent eosinophilia compared to the other three sub-
groups and this difference was highly significant (p =
0.01) between the egg+IgEhi subgroup and the egg-IgElo
subgroup (no evidence of worm exposure) (Table 2).
Furthermore, the median viral load for the egg+IgEhi
subgroup was more than 2-fold higher than that of the
combined HIV+ group shown in Table 1, and nearly 3-
fold higher than those of the egg+IgElo and egg-IgElo
subgroups (Table 2). These were however not statisti-
cally significant (p = 0.12).
HIV negative egg+IgEhi subgroup
The HIV negative, egg+IgEhi subgroup had lymphocyto-
penia and eosinophilia. As in the HIV positives, the HIV
Table 1 Summary of baseline characteristics and haematologic indices of study participants by HIV status
Characteristics HIV-1 Positive (n = 151) HIV-1 Negative (n = 45)
Demographic characteristics
Males 15 11
Females 136 34
Median Age (years) 30.6 40.0
Serum IgE and Helminth Infection Status
Mean total IgE (Ref. range below 70 KU/L) 429.2 kU/L 655.18 kU/L
Mean Ascaris-specific IgE (Ref. range below 0.35 kU/L) 2.15 kU/L 2.86 kU/L
Helminth egg positive (number/total) % (51/124)a 41.1 (18/39)b 46.1
Helminth egg positive and/or positive serology* (99/151) 66.0 (32/45) 71. 1
Ascaris Worm Burden epg** Mean (SD) 170 (86.5) 191 (78.8)
Trichuris Worm Burden epg Mean (SD) 19.8 (36.7) 74.11 (56.2)
Haematological/Viral Indices (Median) (n = 149) (n = 45)
Total lymphocytes ( 1.0-4.0 × 109/L) 1.98 2.22
T lymphocytes (1.1-1.7 × 109/L ) 1.49 1.71
CD8+(0.5-0.9 × 109/L) 0.78 0.47
CD4+ (0.7-1.1 × 109/L) 0.32 0.74
CD4:CD8 ratio 1-1,5 0.4 1.58
NK cells (0.2-0.4 × 109/L) 0.1 0.18
B lymphocytes(0.2-0.4 × 109/L) 0.1 0.24
Median Viral load (copies/ml) 33 317 -
*Evidence of helminth exposure as indicated by faecal egg excretion and/or elevated Ascaris lumbricoides specific IgE. ** Epg is eggs per gram of stool. a Twenty
seven of 151 (HIV+) andb six of 45 ( HIV-) participants did not submit faecal samples. The haematological reference values in brackets were established for the
local population at Tygerberg Hospital and their lower limits differ from those of the CDC reference ranges for CD4+ (0.475-1.616 × 109/L) and (CD8+:0.209- 0.924
× 109/L) [27-29].
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uninfected, egg+IgEhi participants had lower median
values for all lymphocyte subsets except the CD4:CD8
ratio that was highest (Table 3). Total and B lympho-
cytes were significantly lower in the egg+IgEhi compared
to the egg-IgEhi subgroup (p = 0.05). Furthermore, the
egg+IgEhi subgroup had marked eosinophilia compared
to the rest of the HIV-1 negative subgroups and the
absolute eosinophil counts were higher in this egg+IgEhi
group compared to both subgroups with low IgE(egg+-
IgElo) and the (egg-IgElo).
HIV positive Egg+IgElo subgroup
In the HIV positive group, the egg+IgElo participants had
highest absolute numbers for all the lymphocyte subsets
than all the other subgroups (Table 2), and also higher
than the overall values for the entire HIV positive group
shown in Table 1. There were significant differences in
CD4+ (p = 0.01) and CD4:CD8 ratio (p = 0.03) between
the egg+IgElo and the egg-IgElo subgroups. B lymphocyte
values were significantly higher in the egg+IgElo compared
to the egg+IgEhi subgroup (p = 0.02). Additionally, the egg
+IgElo subgroup had the lowest viral load although this was
not statistically significant (p = 0.12). However, a partially
significant difference in viral load was observed between
egg+IgElo and the egg-IgEhi subgroup (p = 0.05) when two
extreme outliers are excluded from the analysis (Table 2).
HIV negative Egg+ IgElo subgroup
Similarly, in the HIV uninfected group, egg+IgElo partici-
pants appeared to have the highest total-, T-, CD8+--
and NK-lymphocyte counts. The total lymphocytes were
significantly higher in this subgroup compared to the
egg+IgEhi subgroup. The CD4+ and CD4:CD8 ratio was
similar to the values for the egg-IgElo subgroup (without
evidence of helminth infection) (Table 3).
HIV positive egg+IgEhi and egg-IgEhi (high IgE) subgroups
Among the HIV infected participants, both subgroups
with elevated IgE (egg+IgEhi and egg-IgEhi) had the high-
est viral loads with 70 878 copies per ml (cpml) and 87
813 cpml respectively compared to the two subgroups
with low Ascaris IgE egg+IgElo and egg-IgElo which had
25 666 cpml and 28 257 cpml, respectively. Although
these differences in viral load were not statistically sig-
nificant, the two subgroups with high IgE had almost
three-fold higher viral loads. In addition to higher virus
burden, the egg+IgEhi subgroup also had relatively
higher eosinophil levels (Table 2).
HIV negative egg+IgEhi and egg-IgEhi subgroups
Likewise, among the HIV uninfected individuals, both
groups with high IgE (egg+IgEhi and egg-IgEhi) had
marked eosinophilia and lower CD4+ counts. Other
Table 3 Comparison of eosinophils and lymphocytes among HIV negative subgroups
SUBGROUPS
Cell Types† Egg+/IgEhi (n = 9) Egg+/IgElo (n = 9) Egg-/IgEhi (n = 11) Egg-/IgElo (n = 10) p-value
Eosinophils 0.37 0.12 0.31 0.22 0.09
Total lymphocytes 1.95 2.79 2.65 2.37 0.05
T lymphocytes 1.40 1.91 1.73 1.83 0.14
CD8+ 0.36 0.49 0.47 0.41 0.49
CD4+ 0.67 0.75 0.68 0.76 0.59
CD4:CD8 ratio 1.86 1.54 1.37 1.57 0.47
B lymphocytes 0.08 0.17 0.23 0.15 0.01
NK lymphocytes 0.22 0.28 0.25 0.24 0.16
†Cells are expressed as medians in count × 109/L blood.
Table 2 Comparison of eosinophils, viral load and lymphocytes among HIV positive subgroups
SUBGROUPS
Cell Types† Egg+IgEhi (n = 21) Egg+IgElo (n = 35) Egg-IgEhi (n = 21) Egg-IgElo (n = 47) p-value
Eosinophils 0.32 0.15 0.18 0.10 0.01
Total lymphocytes 1.72 2.1 1.89 1.98 0.50
T lymphocytes 1.29 1.75 1.39 1.25 0.23
CD8+ 0.66 0.84 0.78 0.66 0.66
CD4+ 0.28 0.41 0.32 0.23 0.01
CD4:CD8 ratio 0.38 0.48 0.37a 0.34 0.03
NK lymphocytes 0.11 0.12 0.10 0.11 0.83
B lymphocytes 0.09 0.15 0.12 0.10 0.03
Viral Load 70 878 25 666 87 813 28 257 0.12
†Cells are expressed medians in count × 109/L and viral load in copies per ml of blood.
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observations in this section included the findings that
low IgE (egg+IgElo and egg-IgElo) subgroups also had
low eosinophil counts, particularly in the HIV unin-
fected groups (Table 3).
Viral loads and levels of immunodeficiency in subgroups
The maximum viral loads in each subgroup were 1 013
265 cpml (egg+IgEhi); 448 447 cpml (egg+IgElo); 1 711 249
cpm (egg-IgEhi) and 3 637 277 cpml (egg-IgElo). In the lat-
ter, three individuals had virus burden exceeding 1 000
000 cpml, and the individual with the highest viral load in
the entire HIV group was found in this subgroup. The vir-
aemia, determined by different grades of virus burden
from 33 000 cpml (based on the median for all HIV posi-
tive study individuals) (Figure 2), and levels of immune
deficiency, determined by CD4+ counts (Figure 3) were
assessed in the four subgroups. The egg+IgEhi subgroup
had the lowest number of individuals with high CD4+
counts and lowest proportion with low viral load. The egg
+IgElo group had the highest number of individuals with
higher CD4+ counts and lower viral loads (Figure 2 and
Figure 3).
Immune Activation profile in HIV positive and HIV
negative groups
HIV positive subgroups
Figure 4 illustrates interactions between the four sub-
groups of the 40 selected HIV positive participants. The
egg+IgEhi subgroup had a statistically significant increased
expression of all activation markers. When the HIV and
helminth co-infected, egg+IgEhi subgroup was compared
to the HIV-singly infected egg-IgElo subgroup, both had
similar median CD4+ counts, which were slightly higher
with 0.27 × 109/L cells in the former compared to 0.22 ×
109/L cells in the egg-IgElo subgroup. The median viral
load was significantly higher in the dually infected egg+-
IgEhi subgroup with 101 007 cpm compared to 4 234 cpm
in the egg-IgElo subgroup (p = 0.01).
It is noted that the viral loads and CD4+ counts could
not be matched before random selection of the subgroups.
Comparisons of activation between these two subgroups
showed that expression of all activation markers was
almost two-fold higher in the egg+IgEhi subgroup. These
results showed a significant difference between the egg+-
IgEhi helminth/HIV co-infected subgroup and the HIV-
singly infected helminth non-infected (egg-IgElo) subgroup
with regards to the level of immune activation.
Further analysis showed that the egg+IgEhi helminth/
HIV co-infected subgroup expressed significantly higher
levels of all activation markers than all the other sub-
groups in the HIV positive group (Figure 4). All these dif-
ferences were statistically highly significant (p≤ 0.01) in
all variables (Figure 4) except for CD4+CD25+ (p = 0.03).
In this subgroup, median CD3+, CD4+ and CD8+ expres-
sion of the classic activation marker, HLA-DR, was
higher than in all the other three subgroups (Figure 4
panels D-F, p≤ 0.01). In addition, median expression of
CCR5 by CD8+ cells exceeded 90% while in CD4+ cells
Figure 2 Levels of viral loads (copies per ml of blood) in the four subgroups of HIV infected participants.
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median CCR5 expression was almost twice as high as in
the egg-IgEhi and the egg-IgElo subgroups.
Furthermore, the early activation marker-CD71 was 2-3
fold higher (p < 0.001) than in the other three subgroups
in both the CD4+ and CD8+ compartments (Figure 4
Panels H and I). Almost all the CD8+ cells were CD38+
in this subgroup and this was statistically significantly
higher (p = 0.01) than in the other subgroups (Figure 4,
Panel G).
The highest levels of percentages of lymphocytes
expressing all activation markers by the egg+IgE+
subgroup is remarkable in view of the fact that in the
preceding section this egg+IgEhi group was shown to
have a tendency towards a generalized reduction of lym-
phocyte populations.
In addition, stool egg positive subgroups (egg+IgEhi and
egg+IgElo) had more than two-fold median CCR5 expres-
sion by CD4+ cells, compared to the stool egg negative
subgroups (egg-IgEhi and egg-IgElo) in the HIV+ group.
Furthermore, in both stool egg positive subgroups, median
expression of CD38 by CD8+ lymphocytes exceeded 90%
and this was statistically significant (Figure 4).
HIV negative subgroups
In the HIV- negative group, the egg+IgEhi subgroup had
lower CD4+ counts compared to the other three sub-
groups. No dramatic increases in activation markers were
observed among these individuals and no statistically sig-
nificant differences were observed in any of the variables
analysed except for the apparent increase (nearly two-fold)
in median CD4+ CCR5+ in the egg+IgEhi and egg+IgElo
subgroups (4.3% and 4.9%) compared to the egg-IgEhi and
the egg-IgElo subgroups (2.2% and 2.4%) respectively. Like-
wise, expression of CCR5 on CD8+ cells was higher in the
egg+IgEhi compared to the egg-IgEhi subgroup (p = 0.09).
A marginally non-significantly higher CD8+ HLA-DR was
also observed in the egg+IgElo compared to the egg-IgEhi
subgroups (p = 0.09).
Discussion
In this study the combined use of coproscopy and serology
not only improved the diagnosis of helminthiasis, but also
facilitated the distinction of four phenotypically different
infection profiles: (i) stool egg positive and high IgE (egg
+IgEhi), (ii) the stool egg positive and low IgE (egg+IgElo),
(iii) the stool egg negative and high IgE (egg-IgEhi) and (iv)
the egg negative, IgE low (egg-IgElo) subgroups. Similarly,
Maizels and Yazdanbakhsh [21] also described three phe-
notypic outcomes of helminth infections. In the present
study, different forms of immune alterations and their pos-
sible effect on HIV infection were assessed within the
defined subgroups.
Overall the prevalence of intestinal helminth infec-
tions was high (40-60%) in adults residing in this
resource-limited study setting. Furthermore, the partici-
pants presented with a high IgE responder profile as
shown by more than six-fold total and specific IgE
above the reference ranges in both HIV+ and HIV-
groups. This finding concurs with earlier suggestions
that Africans generally present with elevated IgE levels
as demonstrated in studies conducted in a similar eth-
nic group [30,31]. IgE class switching is mediated by
CD4+ Th2 cells [32], and it is at present unclear
whether the high IgE in this population is due to a
genetic predisposition or environmental influences that
mediate Th2 cell predominance.
Figure 3 Levels of immunodeficiency by CD4 counts (cells per
ml of blood) in the four subgroups of HIV infected
participants.
Figure 4 Box and whisker plots for lymphocyte surface
expression of activation markers in HIV+ subgroups, and
Kruskal Wallis Anova comparison of medians for significant
differences between subgroups (at p value ≤ 0.05), where Egg
+IgEhi denotes helminth egg positive and elevated Ascaris
lumbricoides IgE subgroup, Egg+IgElo represents egg positive
and low A. lumbricoides IgE subgroup, Egg-IgEhi designates egg
negative and high A. lumbricoides IgE subgroup, and Egg-Iglo stands
for helminth egg negative and low A. lumbricoides IgE subgroup.
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The expected hypothetical study outcome was that dual
infection would adversely impact on the immune profile
of affected hosts compared to singly-or non-infected
counterparts. Comparisons between singly and dually-
infected HIV positive subgroups revealed no significant
differences in lymphocyte profiles. There was significant
eosinophilia in the HIV-helminth co-infected subgroup.
In the absence of HIV infection, a tendency to increased
lymphocytes and marginally lower eosinophils was
observed in the egg-IgElo compared to the typical hel-
minth infected egg+IgEhi subgroup. The differences in
the other cell types were not statistically significant
between these two groups. The relatively smaller num-
bers in the HIV negative subgroups could have influ-
enced the power to obtain statistically significant
differences. The fact that no such differences were noted
in the HIV positive subgroups suggests that HIV-induced
immunosuppression could be responsible for masking
any differences in the latter. Firstly the HIV+, egg-IgElo
subgroup had the lowest median CD4+ counts. Secondly,
similar percentages of participants in the egg+IgEhi and
egg-IgElo subgroups were severely immunocompromised
(less than 0, 2 × 109 cells/L CD4+ counts) and virus bur-
den was similar in the two subgroups (Figure 3).
When the dually-infected subgroups were analysed, sev-
eral observations revealed that certain immunological
phenoytypes of helminth infection may favour HIV repli-
cation, thus by inference lending support to the study
hypothesis that helminthiasis might enhance virus repli-
cation. Firstly, typical helminth infection (as reflected by
the egg+IgEhi status) was accompanied by eosinophilia,
approximately three-fold higher viral loads and generally
lower absolute counts for all lymphocyte populations
when compared to the other three subgroups. This ten-
dency was observed in both HIV positive and negative
groups. This finding concurs with the report that chronic
helminth infections in adults resulted in disruptions in
peripheral T cell populations [33]. In addition, all mea-
sured activation markers were significantly elevated in the
egg+IgEhi and HIV co-infected subgroup. Nearly all the
CD8+ cells were CD38-positive in the egg+IgEhi subgroup
(Figure 4). Immune activation has been widely implicated
as playing a pivotal role in HIV pathogenesis through
various pathways [1,2,34-36].
The observed decrease in lymphocyte populations
among the egg+IgEhi individuals in this study, could indir-
ectly relate to a compromised immunological ability to
respond to HIV infection. Lymphocytes play a pivotal role
in immune response to infection in general and in con-
taining the HI virus [32]. Eosinophils are proposed to
increase the number of activated cells that are infectable
with HIV since they express the CD4 receptor molecule
and in vitro studies showed that when these cells are acti-
vated, they can be infected by HIV [37,38]. These
suggestions are in agreement with the study hypothesis
and findings.
Furthermore, both subgroups with elevated IgE (egg+-
IgEhi and egg-IgEhi had eosinophilia, low CD4+ counts
(especially in the HIV- group) and three-fold higher
viral load (in HIV+group) compared to the low IgE sub-
groups (the egg+IgElo and egg-IgElo). Both eosinophilia
and high IgE are classic Th2 responses that are univer-
sally induced by helminth infections [21,32]. The asso-
ciation of these mediators with higher viral loads
supports the concept that Th2 polarisation by helminths
suppresses the protective Th1 responses and hence pro-
motes HIV replication [1,39,40].
In direct contrast to these responses of high IgE sub-
groups, the egg+IgElo subgroup had significantly higher
absolute CD4+ counts and helper/suppressor ratios and
generally higher absolute numbers of all lymphocyte
subsets accompanied by the lowest viral load. This find-
ing suggests a low IgE phenotype with a better ability to
control the HIV viral infection in these individuals pre-
senting as modified Th2 responders [21].
Several limitations are noted in this study. The cross
sectional design was a major shortcoming as both HIV
and helminth infections are chronic conditions. HIV
infection has different stages, each characterised by dif-
ferent pathogenesis and immunologic features. Likewise,
helminth infections have different life cycle phases that
are associated with specific immune responses. Thus, an
ideal design for studies of co-infections with these two
organisms would be a prospective cohort study with ran-
domised sampling. The small sample size also limited the
study. The majority of participants were females in both
HIV positive and negative groups and the HIV negative
participants were slightly older (10 years difference in
median ages) than the HIV positive group. Both age and
gender may affect many immunological and haematologi-
cal parameters [1]. These factors could possibly confound
the study; nevertheless, it was encouraging to find some
significant results despite the listed limitations.
Conclusions
Our results suggest that HIV immune responses are
impaired by helminth infections in certain susceptible
groups of individuals, particularly in individuals who
excrete worm eggs and have high parasite IgE in serum.
Helminth-induced Th2 bias is also associated with
impaired immune response to HIV. Individuals with a
modified Th2 response to helminths are better able to con-
trol HIV.
The present work contributes to the body of new
knowledge in South Africa and provide evidence that the
presence of intestinal parasite eggs in stools of infested
individuals represents only a part of the helminth infec-
tion phenotype, which can be further delineated by levels
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of helminth-specific IgE (and IgG4) [21]. Grouping
according to stool egg positivity alone would misclassify
infection and non-infection; obscure the recognition of
additional phenotypes with major implications for the
interpretation of studies addressing immunological
effects of co-infections with helminths. This has implica-
tions for the design of future studies aimed at analysing
helminth co-infection and more importantly, interpreta-
tion of such studies. Parasite IgE serology should be used
to supplement egg detection and delineate the different
response phenotypes in future co-infection studies.
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